Haemonetics Additive Solution Formula 3 (AS-3) (Haemonetics Corporation)


Welcome to the PulseAid listing for the Haemonetics Additive Solution Formula 3 (AS-3) drug offered from Haemonetics Corporation. This Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Haemonetics Corporation
NON-PROPRIETARY NAME: CITRIC ACID MONOHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, SODIUM CHLORIDE, ADENINE, ANHYDROUS DEXTROSE, TRISODIUM CITRATE DIHYDRATE
SUBSTANCE NAME: CITRIC ACID MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; SODIUM CHLORIDE; ADENINE; ANHYDROUS DEXTROSE; TRISODIUM CITRATE DIHYDRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA]
ROUTE: EXTRACORPOREAL
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2013-01-10
END MARKETING DATE: 0000-00-00


Haemonetics Additive Solution Formula 3 (AS-3) HUMAN PRESCRIPTION DRUG Details:

Item DescriptionHaemonetics Additive Solution Formula 3 (AS-3) from Haemonetics Corporation
LABELER NAME: Haemonetics Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 4.2; 27.6; 41; 3; 100; 58.8(mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL)
START MARKETING DATE: 2013-01-10
END MARKETING DATE: 0000-00-00
PRODUCT ID: 57826-460_5ae72cea-f76f-4988-aaf3-a17aea22b69f
PRODUCT NDC: 57826-460
APPLICATION NUMBER: BN000127

Other CITRIC ACID MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; SODIUM CHLORIDE; ADENINE; ANHYDROUS DEXTROSE; TRISODIUM CITRATE DIHYDRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Haemonetics CorporationHaemonetics Additive Solution Formula 3 (AS-3)